Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2020

01-04-2020 | Review Article

Questionnaires on adherence to antihypertensive treatment: a systematic review of published questionnaires and their psychometric properties

Authors: Elisa Pareja-Martínez, Elisabeth Esquivel-Prados, Fernando Martínez-Martínez, José P. García-Corpas

Published in: International Journal of Clinical Pharmacy | Issue 2/2020

Login to get access

Abstract

Background Non-adherence to antihypertensive treatment is currently considered one of the most significant risk factors in failure to achieve controlled blood pressure values. It is therefore extremely important to measure patient adherence to antihypertensive treatment. One way to measure adherence is through questionnaires. Numerous questionnaires for measuring adherence to antihypertensive treatment have been validated, but it not easy to choose one of them as being more appropriate than all of the others. Aim of the review The aim of this study was to identify and assess questionnaires designed to measure non-adherence to antihypertensive treatment, and to discuss their psychometric properties. Method A systematic review of the literature contained in PubMed and Scopus databases was undertaken to identify validated questionnaires on adherence to antihypertensive treatment up to October 2017. PRISMA guidelines were followed to conduct and report this review. Selection of articles and data extraction were performed by two independent researchers. When there was lack of agreement, a third researcher mediated in the discussion between the first two authors so that consensus could be reached. Results 39 articles were obtained containing 17 different questionnaires for measuring adherence to antihypertensive treatment. These questionnaires were validated in 15 countries. The number of items in the questionnaires ranged from three in QAM-Q to 33 in TAQPH. Hill-Bone compliance to high blood pressure therapy scale, Morisky-Green-Levine test and an 8-item Self-Reported Medication Adherence Measurement were the most widely validated questionnaires. Validity was analyzed more than reliability. Many of the questionnaires do not provide information on content validity. Construct validity and concurrent validity are analyzed in almost all of the questionnaires, and give highly variable results. By contrast, known-groups validity was not analyzed to any great degree. As regards reliability, almost all of the questionnaires provided Cronbach’s alpha information with reasonably acceptable results, but temporal stability was not analyzed to any great degree. Conclusion None of the questionnaires included in the review demonstrates fulfilling all of the validity tests (content validity, construct validity and criterion-related validity) and reliability tests (homogeneity and temporal stability) in an acceptable manner. Therefore, none of them can be considered a Gold Standard.
Literature
1.
go back to reference NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet Lond Engl. 2017;389:37–55. NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet Lond Engl. 2017;389:37–55.
3.
go back to reference Patricia MK, Megan W, Kristi R, Paul KW, Jiang H. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22:11–9. Patricia MK, Megan W, Kristi R, Paul KW, Jiang H. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22:11–9.
4.
go back to reference Mancia G, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, et al. ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3104-3021. Mancia G, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, et al. ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3104-3021.
5.
go back to reference Costa F. Improving adherence to treatment and reducing economic costs of hypertension: the role of olmesartan-based treatment. High Blood Press Cardiovasc Prev. 2017;24:265–74.PubMed Costa F. Improving adherence to treatment and reducing economic costs of hypertension: the role of olmesartan-based treatment. High Blood Press Cardiovasc Prev. 2017;24:265–74.PubMed
6.
go back to reference Lehmann A, Aslani P, Ahmed R, Celio J, Gauchet A, Bedouch P, et al. Assessing medication adherence: options to consider. Int J Clin Pharm. 2014;36:55–69.PubMed Lehmann A, Aslani P, Ahmed R, Celio J, Gauchet A, Bedouch P, et al. Assessing medication adherence: options to consider. Int J Clin Pharm. 2014;36:55–69.PubMed
7.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6:e1000097.PubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6:e1000097.PubMedPubMedCentral
8.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.PubMedPubMedCentral Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.PubMedPubMedCentral
9.
go back to reference Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15:90–6.PubMed Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15:90–6.PubMed
10.
go back to reference Krousel-Wood M, Jannu A, Re RN, Muntner P, Desalvo K. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci. 2005;330:128–33.PubMed Krousel-Wood M, Jannu A, Re RN, Muntner P, Desalvo K. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci. 2005;330:128–33.PubMed
11.
go back to reference Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the Hill-Bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis. 2006;16:286–91.PubMed Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the Hill-Bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis. 2006;16:286–91.PubMed
12.
go back to reference Karademir M, Koseoglu IH, Vatansever K, Van Den Akker M. Validity and reliability of the Turkish version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary health care settings. Eur J Gen Pract. 2009;15:207–11.PubMed Karademir M, Koseoglu IH, Vatansever K, Van Den Akker M. Validity and reliability of the Turkish version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary health care settings. Eur J Gen Pract. 2009;15:207–11.PubMed
13.
go back to reference Song Y, Han H-R, Song H-J, Nam S, Nguyen T, Kim MT. Psychometric evaluation of Hill-Bone medication adherence subscale. Asian Nurs Res. 2011;5:183–8. Song Y, Han H-R, Song H-J, Nam S, Nguyen T, Kim MT. Psychometric evaluation of Hill-Bone medication adherence subscale. Asian Nurs Res. 2011;5:183–8.
14.
go back to reference Uchmanowicz I, Jankowska-Polańska B, Chudiak A, Szymańska-Chabowska A, Mazur G. Psychometric evaluation of the Polish adaptation of the Hill-Bone compliance to high blood pressure therapy scale. BMC Cardiovasc Disord. 2016;16:87.PubMed Uchmanowicz I, Jankowska-Polańska B, Chudiak A, Szymańska-Chabowska A, Mazur G. Psychometric evaluation of the Polish adaptation of the Hill-Bone compliance to high blood pressure therapy scale. BMC Cardiovasc Disord. 2016;16:87.PubMed
15.
go back to reference Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.PubMed Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.PubMed
16.
go back to reference van de Steeg N, Sielk M, Pentzek M, Bakx C, Altiner A. Drug-adherence questionnaires not valid for patients taking blood-pressure-lowering drugs in a primary health care setting. J Eval Clin Pract. 2009;15:468–72.PubMed van de Steeg N, Sielk M, Pentzek M, Bakx C, Altiner A. Drug-adherence questionnaires not valid for patients taking blood-pressure-lowering drugs in a primary health care setting. J Eval Clin Pract. 2009;15:468–72.PubMed
17.
go back to reference Ben AJ, Neumann CR, Mengue SS. The brief medication questionnaire and Morisky–Green test to evaluate medication adherence. Rev Saude Publica. 2012;46:279–89.PubMed Ben AJ, Neumann CR, Mengue SS. The brief medication questionnaire and Morisky–Green test to evaluate medication adherence. Rev Saude Publica. 2012;46:279–89.PubMed
18.
go back to reference Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10:348–54. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10:348–54.
19.
go back to reference Oliveira-Filho AD, Barreto-Filho JA, Neves SJF, de Lyra Junior DP. Association between the 8-item Morisky medication adherence scale (MMAS-8) and blood pressure control. Arq Bras Cardiol. 2012;99:649–58.PubMed Oliveira-Filho AD, Barreto-Filho JA, Neves SJF, de Lyra Junior DP. Association between the 8-item Morisky medication adherence scale (MMAS-8) and blood pressure control. Arq Bras Cardiol. 2012;99:649–58.PubMed
20.
go back to reference Korb-Savoldelli V, Gillaizeau F, Pouchot J, Lenain E, Postel-Vinay N, Plouin P-F, et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens Greenwich Conn. 2012;14:429–34. Korb-Savoldelli V, Gillaizeau F, Pouchot J, Lenain E, Postel-Vinay N, Plouin P-F, et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens Greenwich Conn. 2012;14:429–34.
21.
go back to reference Shin D-S, Kim C-J. Psychometric evaluation of a Korean version of the 8-item medication adherence scale in rural older adults with hypertension. Aust J Rural Health. 2013;21:336–42.PubMed Shin D-S, Kim C-J. Psychometric evaluation of a Korean version of the 8-item medication adherence scale in rural older adults with hypertension. Aust J Rural Health. 2013;21:336–42.PubMed
22.
go back to reference de Oliveira-Filho AD, Morisky DE, Neves SJF, Costa FA, de Lyra DP. The 8-item Morisky Medication adherence scale: validation of a Brazilian–Portuguese version in hypertensive adults. Res Soc Adm Pharm. 2014;10:554–61. de Oliveira-Filho AD, Morisky DE, Neves SJF, Costa FA, de Lyra DP. The 8-item Morisky Medication adherence scale: validation of a Brazilian–Portuguese version in hypertensive adults. Res Soc Adm Pharm. 2014;10:554–61.
23.
go back to reference Kim J-H, Lee W-Y, Hong Y-P, Ryu W-S, Lee KJ, Lee W-S, et al. Psychometric properties of a short self-reported measure of medication adherence among patients with hypertension treated in a busy clinical setting in Korea. J Epidemiol. 2014;24:132–40.PubMedPubMedCentral Kim J-H, Lee W-Y, Hong Y-P, Ryu W-S, Lee KJ, Lee W-S, et al. Psychometric properties of a short self-reported measure of medication adherence among patients with hypertension treated in a busy clinical setting in Korea. J Epidemiol. 2014;24:132–40.PubMedPubMedCentral
24.
go back to reference Hacıhasanoğlu Aşılar R, Gözüm S, Çapık C, Morisky DE. Reliability and validity of the Turkish form of the eight-item Morisky medication adherence scale in hypertensive patients. Anadolu Kardiyol Derg AKD Anatol J Cardiol. 2014;14:692–700. Hacıhasanoğlu Aşılar R, Gözüm S, Çapık C, Morisky DE. Reliability and validity of the Turkish form of the eight-item Morisky medication adherence scale in hypertensive patients. Anadolu Kardiyol Derg AKD Anatol J Cardiol. 2014;14:692–700.
25.
go back to reference Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian version of the 8-item Morisky medication adherence scale (MMAS-8) in Iranian hypertensive patients. Glob J Health Sci. 2015;7:173–83.PubMed Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian version of the 8-item Morisky medication adherence scale (MMAS-8) in Iranian hypertensive patients. Glob J Health Sci. 2015;7:173–83.PubMed
26.
go back to reference Pareja-Martínez E, Esquivel-Prados E, Franco L, García-Corpas JP. Adherence to antihypertensive therapy in community pharmacy: evaluating the psychometric properties of the Morisky medication adherence scale (MMAS-8) translated into Spanish. Pilot study. Lat Am J Pharm. 2015;34:86–93. Pareja-Martínez E, Esquivel-Prados E, Franco L, García-Corpas JP. Adherence to antihypertensive therapy in community pharmacy: evaluating the psychometric properties of the Morisky medication adherence scale (MMAS-8) translated into Spanish. Pilot study. Lat Am J Pharm. 2015;34:86–93.
27.
go back to reference Gallagher BD, Muntner P, Moise N, Lin JJ, Kronish IM. Are two commonly used self-report questionnaires useful for identifying antihypertensive medication nonadherence? J Hypertens. 2015;33:1108–13.PubMedPubMedCentral Gallagher BD, Muntner P, Moise N, Lin JJ, Kronish IM. Are two commonly used self-report questionnaires useful for identifying antihypertensive medication nonadherence? J Hypertens. 2015;33:1108–13.PubMedPubMedCentral
28.
go back to reference Pandey A, Raza F, Velasco A, Brinker S, Ayers C, Das SR, et al. Comparison of Morisky medication adherence scale with therapeutic drug monitoring in apparent treatment-resistant hypertension. J Am Soc Hypertens JASH. 2015;9(420–426):e2. Pandey A, Raza F, Velasco A, Brinker S, Ayers C, Das SR, et al. Comparison of Morisky medication adherence scale with therapeutic drug monitoring in apparent treatment-resistant hypertension. J Am Soc Hypertens JASH. 2015;9(420–426):e2.
29.
go back to reference Okello S, Nasasira B, Muiru ANW, Muyingo A. Validity and reliability of a self-reported measure of antihypertensive medication adherence in Uganda. PLoS ONE. 2016;11:e0158499.PubMedPubMedCentral Okello S, Nasasira B, Muiru ANW, Muyingo A. Validity and reliability of a self-reported measure of antihypertensive medication adherence in Uganda. PLoS ONE. 2016;11:e0158499.PubMedPubMedCentral
30.
go back to reference Jankowska-Polanska B, Uchmanowicz I, Chudiak A, Dudek K, Morisky DE, Szymanska-Chabowska A. Psychometric properties of the Polish version of the eight-item Morisky medication adherence scale in hypertensive adults. Patient Prefer Adherence. 2016;10:1759–66.PubMedPubMedCentral Jankowska-Polanska B, Uchmanowicz I, Chudiak A, Dudek K, Morisky DE, Szymanska-Chabowska A. Psychometric properties of the Polish version of the eight-item Morisky medication adherence scale in hypertensive adults. Patient Prefer Adherence. 2016;10:1759–66.PubMedPubMedCentral
31.
go back to reference Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African–American patients. J Clin Epidemiol. 2003;56:520–9.PubMed Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African–American patients. J Clin Epidemiol. 2003;56:520–9.PubMed
32.
go back to reference Fernandez S, Chaplin W, Schoenthaler AM, Ogedegbe G. Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. J Behav Med. 2008;31:453–62.PubMedPubMedCentral Fernandez S, Chaplin W, Schoenthaler AM, Ogedegbe G. Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. J Behav Med. 2008;31:453–62.PubMedPubMedCentral
33.
go back to reference Gozum S, Hacihasanoglu R. Reliability and validity of the Turkish adaptation of medication adherence self-efficacy scale in hypertensive patients. Eur J Cardiovasc Nurs J Work Group Cardiovasc Nurs Eur Soc Cardiol. 2009;8:129–36. Gozum S, Hacihasanoglu R. Reliability and validity of the Turkish adaptation of medication adherence self-efficacy scale in hypertensive patients. Eur J Cardiovasc Nurs J Work Group Cardiovasc Nurs Eur Soc Cardiol. 2009;8:129–36.
34.
go back to reference Hacihasanoğlu R, Gözüm S, Capik C. Validity of the Turkish version of the medication adherence self-efficacy scale-short form in hypertensive patients. Anadolu Kardiyol Derg AKD Anatol J Cardiol. 2012;12:241–8. Hacihasanoğlu R, Gözüm S, Capik C. Validity of the Turkish version of the medication adherence self-efficacy scale-short form in hypertensive patients. Anadolu Kardiyol Derg AKD Anatol J Cardiol. 2012;12:241–8.
35.
go back to reference Saffari M, Zeidi IM, Fridlund B, Chen H, Pakpour AH. A Persian adaptation of medication adherence self-efficacy scale (MASES) in hypertensive patients: psychometric properties and factor structure. High Blood Press Cardiovasc Prev Off J Ital Soc Hypertens. 2015;22:247–55. Saffari M, Zeidi IM, Fridlund B, Chen H, Pakpour AH. A Persian adaptation of medication adherence self-efficacy scale (MASES) in hypertensive patients: psychometric properties and factor structure. High Blood Press Cardiovasc Prev Off J Ital Soc Hypertens. 2015;22:247–55.
36.
go back to reference Ma C, Chen S, You L, Luo Z, Xing C. Development and psychometric evaluation of the treatment adherence questionnaire for patients with hypertension. J Adv Nurs. 2012;68:1402–13.PubMed Ma C, Chen S, You L, Luo Z, Xing C. Development and psychometric evaluation of the treatment adherence questionnaire for patients with hypertension. J Adv Nurs. 2012;68:1402–13.PubMed
37.
go back to reference Dehghan M, Dehghan-Nayeri N, Iranmanesh S. Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension. ARYA Atheroscler. 2016;12:76–86.PubMed Dehghan M, Dehghan-Nayeri N, Iranmanesh S. Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension. ARYA Atheroscler. 2016;12:76–86.PubMed
38.
go back to reference de Santa Helena ET, Nemes MIB, Eluf-Neto J. Development and validation of a multidimensional questionnaire assessing non-adherence to medicines. Rev Saude Publica. 2008;42:764–7.PubMed de Santa Helena ET, Nemes MIB, Eluf-Neto J. Development and validation of a multidimensional questionnaire assessing non-adherence to medicines. Rev Saude Publica. 2008;42:764–7.PubMed
39.
go back to reference Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008;61:282–8.PubMed Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008;61:282–8.PubMed
40.
go back to reference Pérez-Escamilla B, Franco-Trigo L, Moullin JC, Martínez-Martínez F, García-Corpas JP. Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer Adherence. 2015;9:569–78.PubMedPubMedCentral Pérez-Escamilla B, Franco-Trigo L, Moullin JC, Martínez-Martínez F, García-Corpas JP. Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer Adherence. 2015;9:569–78.PubMedPubMedCentral
42.
go back to reference Martínez JW, Villa Perea JA, Jaramillo J, Quintero Betancur AM, Calderón V. Validación del cuestionario de adherencia al tratamiento anti hipertensivo Martín Bayarré Grau. Rev Med Risaralda. 2011;17:101–5. Martínez JW, Villa Perea JA, Jaramillo J, Quintero Betancur AM, Calderón V. Validación del cuestionario de adherencia al tratamiento anti hipertensivo Martín Bayarré Grau. Rev Med Risaralda. 2011;17:101–5.
43.
go back to reference Strainer DL, Norman GR, Cairney J. Health measurement scales. A practical guide to their development and use. 5th ed. Oxford: Oxford University Press; 2015. Strainer DL, Norman GR, Cairney J. Health measurement scales. A practical guide to their development and use. 5th ed. Oxford: Oxford University Press; 2015.
44.
go back to reference DeVellis RF. Scale development. Theory and applications. 3rd ed. California: Sage Publication; 2012. DeVellis RF. Scale development. Theory and applications. 3rd ed. California: Sage Publication; 2012.
45.
go back to reference Powell KR, Peterson SR. Coverage and quality: a comparison of web of science and scopus databases for reporting faculty nursing publication metrics. Nurs Outlook. 2017;65:572–8.PubMed Powell KR, Peterson SR. Coverage and quality: a comparison of web of science and scopus databases for reporting faculty nursing publication metrics. Nurs Outlook. 2017;65:572–8.PubMed
46.
go back to reference Johnson MJ, Rogers S. Development of the purposeful action medication-taking questionnaire. West J Nurs Res. 2006;28:335–51.PubMed Johnson MJ, Rogers S. Development of the purposeful action medication-taking questionnaire. West J Nurs Res. 2006;28:335–51.PubMed
47.
go back to reference Wetzels G, Nelemans P, van Wijk B, Broers N, Schouten J, Prins M. Determinants of poor adherence in hypertensive patients: development and validation of the «Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire». Patient Educ Couns. 2006;64:151–8.PubMed Wetzels G, Nelemans P, van Wijk B, Broers N, Schouten J, Prins M. Determinants of poor adherence in hypertensive patients: development and validation of the «Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire». Patient Educ Couns. 2006;64:151–8.PubMed
48.
go back to reference He W, Bonner A, Anderson D. Patient reported adherence to hypertension treatment: A revalidation study. Eur J Cardiovasc Nurs. 2016;15:150–6.PubMed He W, Bonner A, Anderson D. Patient reported adherence to hypertension treatment: A revalidation study. Eur J Cardiovasc Nurs. 2016;15:150–6.PubMed
Metadata
Title
Questionnaires on adherence to antihypertensive treatment: a systematic review of published questionnaires and their psychometric properties
Authors
Elisa Pareja-Martínez
Elisabeth Esquivel-Prados
Fernando Martínez-Martínez
José P. García-Corpas
Publication date
01-04-2020
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 2/2020
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-00981-x

Other articles of this Issue 2/2020

International Journal of Clinical Pharmacy 2/2020 Go to the issue